CASI PHARMACEUTICALS INC (CASI) Stock Analyst Earnings Estimates
NASDAQ:CASI - Nasdaq - KYG1933S1012 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 43.107M 42.89% | 33.879M -21.41% | 28.537M -15.77% | 12.75M -55.32% | -100.00% | 11.399M | 31.253M 174.17% | 47.46M 51.86% | 61.413M 29.40% | |||
| EBITDA YoY % growth | -24.069M 28.08% | -21.539M 10.51% | -32.081M -48.94% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -26.491M 24.92% | -25.28M 4.57% | -34.412M -36.12% | -33.635M 2.26% | -29.428M 12.51% | -25.909M 11.96% | -33.648M -29.87% | -25.966M 22.83% | -11.019M 57.56% | -3.891M 64.69% | 5.128M 231.78% | |
| Operating Margin | -61.45% | -74.62% | -120.59% | -263.80% | N/A | N/A | N/A | -227.79% | -35.26% | -8.20% | 8.35% | |
| EPS YoY % growth | -3.40 -25.93% | -2.02 40.59% | N/A -29.27% | -2.11 19.14% | -1.66 21.26% | -1.10 33.74% | 1.32 219.44% | 1.59 20.93% | 1.83 14.74% | N/A | N/A |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.48 12.84% | -0.52 5.42% | -0.42 31.67% | -0.42 39.39% |
| Revenue Q2Q % growth | 6.426M 61.50% | -100.00% | -100.00% | -100.00% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -7.582M 20.64% | -8.554M -5.80% | -7.056M 6.59% | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.69 2.82% | -0.62 | -0.07 | -10.90% |
| Q4 2024 Q2Q % growth | -36.00% | -0.61 | % | |
| Q3 2024 Q2Q % growth | -0.55 -57.14% | -0.63 | 0.08 | 13.03% |
| Q2 2024 Q2Q % growth | -0.55 28.57% | -0.64 | 0.09 | 14.41% |
| Q1 2024 Q2Q % growth | -0.71 -57.78% | -0.05 | -0.66 | -1,292.16% |
| Q4 2023 Q2Q % growth | -0.45 75.81% | -0.24 | -0.21 | -83.82% |
| Q3 2023 Q2Q % growth | -0.35 7.89% | -0.57 | 0.22 | 38.73% |
| Q2 2023 Q2Q % growth | -0.77 -37.50% | -0.51 | -0.26 | -50.98% |
| Q1 2023 Q2Q % growth | -0.45 25.00% | -0.65 | 0.20 | 31.07% |
| Q4 2022 Q2Q % growth | -1.86 -365.00% | -0.38 | -1.48 | -392.85% |
| Q3 2022 Q2Q % growth | -0.38 45.71% | -0.47 | 0.09 | 19.59% |
| Q2 2022 Q2Q % growth | -0.56 -12.00% | -0.65 | 0.09 | 14.22% |
| Q1 2022 Q2Q % growth | -0.60 45.45% | -0.88 | 0.28 | 32.13% |
| Q4 2021 Q2Q % growth | -0.40 66.67% | -0.58 | 0.18 | 30.80% |
| Q3 2021 Q2Q % growth | -0.70 50.00% | -0.56 | -0.14 | -24.78% |
| Q2 2021 Q2Q % growth | -0.50 28.57% | -0.74 | 0.24 | 32.39% |
| Q1 2021 Q2Q % growth | -1.10 -22.22% | -0.61 | -0.49 | -79.74% |
| Q4 2020 Q2Q % growth | -1.20 | -0.71 | -0.49 | -68.07% |
| Q3 2020 Q2Q % growth | -1.40 -40.00% | -0.56 | -0.84 | -149.55% |
| Q2 2020 Q2Q % growth | -0.70 56.25% | -0.82 | 0.12 | 14.22% |
| Q1 2020 Q2Q % growth | -0.90 | -1.12 | 0.22 | 19.79% |
| Q4 2019 Q2Q % growth | -1.20 | -1.12 | -0.08 | -6.95% |
| Q3 2019 Q2Q % growth | -1.00 | -1.12 | 0.12 | 10.87% |
| Q2 2019 Q2Q % growth | -1.60 | -0.92 | -0.68 | -74.29% |
| Q1 2019 Q2Q % growth | -0.90 | -0.92 | 0.02 | 1.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 6.24M 83.04% | 6.222M | 18K | 0.29% |
| Q4 2024 Q2Q % growth | 13.356M 94.30% | 7.542M | 5.814M | 77.09% |
| Q3 2024 Q2Q % growth | 7.793M -11.82% | 4.651M | 3.142M | 67.56% |
| Q2 2024 Q2Q % growth | 3.979M -59.48% | 4.52M | -541K | -11.97% |
| Q1 2024 Q2Q % growth | 3.409M -59.16% | 12.24M | -8.831M | -72.15% |
| Q4 2023 Q2Q % growth | 6.874M -54.95% | 9.6M | -2.726M | -28.40% |
| Q3 2023 Q2Q % growth | 8.838M -13.46% | 10.608M | -1.77M | -16.69% |
| Q2 2023 Q2Q % growth | 9.82M 14.55% | 10.292M | -472K | -4.59% |
| Q1 2023 Q2Q % growth | 8.347M -7.89% | 9.282M | -935K | -10.07% |
| Q4 2022 Q2Q % growth | 15.259M 66.62% | 11.009M | 4.25M | 38.60% |
| Q3 2022 Q2Q % growth | 10.213M 25.90% | 10.098M | 115K | 1.14% |
| Q2 2022 Q2Q % growth | 8.573M 19.70% | 8.033M | 540K | 6.72% |
| Q1 2022 Q2Q % growth | 9.062M 57.98% | 9.418M | -356K | -3.78% |
| Q4 2021 Q2Q % growth | 9.158M 89.92% | 9.248M | -90K | -0.97% |
| Q3 2021 Q2Q % growth | 8.112M 91.23% | 7.689M | 423K | 5.50% |
| Q2 2021 Q2Q % growth | 7.162M 168.14% | 6.14M | 1.022M | 16.64% |
| Q1 2021 Q2Q % growth | 5.736M 68.41% | 5.151M | 585K | 11.36% |
| Q4 2020 Q2Q % growth | 4.822M 258.78% | 4.538M | 284K | 6.26% |
| Q3 2020 Q2Q % growth | 4.242M 52.21% | 3.512M | 730K | 20.79% |
| Q2 2020 Q2Q % growth | 2.671M | 3.825M | -1.154M | -30.17% |
| Q1 2020 Q2Q % growth | 3.406M | 803.76K | 2.602M | 323.76% |
| Q4 2019 Q2Q % growth | 1.344M | 1.184M | 160K | 13.51% |
| Q3 2019 Q2Q % growth | 2.787M | 738.48K | 2.049M | 277.40% |
| Q2 2019 Q2Q % growth | 862.92K | -862.92K | -100.00% | |
| Q1 2019 Q2Q % growth | 627.3K | -627.3K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | N/A | 0% | 0% |
| Revenue | 0% | N/A | 0% | -33.51% |